The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of neoadjuvant chemotherapy (NACT) with 5-flurouracil, epirubicin (100mg), cyclophosphamide (FEC100) followed by docetaxel (D) (75mg) versus adriamycin and cyclophosphamide (AC) followed by docetaxel (100mg) in locally advanced breast cancer (LABC): A randomized clinical study.
 
Smita Kayal
No Relationships to Disclose
 
Dubashi Biswajit
No Relationships to Disclose
 
Sunu Lazar Cyriac
No Relationships to Disclose
 
Bhawana Badhe
No Relationships to Disclose
 
Kadambari D
No Relationships to Disclose
 
Deepak Bharathi
No Relationships to Disclose
 
Swaruparani D
No Relationships to Disclose
 
Gopinath S
No Relationships to Disclose
 
Dhanraj K
No Relationships to Disclose